source
- Phase 3 MANEUVER trial shows pimicotinib improves response and pain in advanced TGCT, supporting FDA NDA acceptanceThe phase 3 MANEUVER study evaluated pimicotinib in patients with advanced diffuse tenosynovial giant cell tumor. The trial compared the oral agent to placebo and collected both clinical and patien…
- STAT+: How a global effort to explore the ‘dark proteome’ is upending our understanding of human diseaseAn international team has found thousands of mini-proteins, including some involved in cell division and DNA repair, as well as several unique to cancer cells.